China Resources Medical Holdings Future Growth
Future criteria checks 3/6
China Resources Medical Holdings is forecast to grow earnings and revenue by 33.8% and 5.8% per annum respectively. EPS is expected to grow by 37% per annum. Return on equity is forecast to be 11.9% in 3 years.
Key information
33.8%
Earnings growth rate
37.0%
EPS growth rate
Healthcare earnings growth | 19.5% |
Revenue growth rate | 5.8% |
Future return on equity | 11.9% |
Analyst coverage | Low |
Last updated | 24 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 11,913 | 881 | N/A | N/A | 2 |
12/31/2025 | 11,594 | 817 | N/A | N/A | 4 |
12/31/2024 | 10,806 | 672 | N/A | N/A | 3 |
12/31/2023 | 10,108 | 258 | N/A | N/A | N/A |
9/30/2023 | 8,640 | 253 | N/A | N/A | N/A |
6/30/2023 | 7,529 | 292 | 733 | 1,070 | N/A |
3/31/2023 | 6,575 | 215 | 553 | 849 | N/A |
12/31/2022 | 5,620 | 139 | 374 | 627 | N/A |
9/30/2022 | 5,929 | 323 | 432 | 682 | N/A |
6/30/2022 | 5,881 | 463 | 447 | 680 | N/A |
3/31/2022 | 5,164 | 441 | 479 | 695 | N/A |
12/31/2021 | 4,447 | 418 | 512 | 710 | N/A |
9/30/2021 | 4,031 | 410 | 392 | 628 | N/A |
6/30/2021 | 3,615 | 402 | 271 | 546 | N/A |
3/31/2021 | 3,183 | 356 | 349 | 595 | N/A |
12/31/2020 | 2,751 | 310 | 426 | 644 | N/A |
9/30/2020 | 2,404 | 313 | 483 | 614 | N/A |
6/30/2020 | 2,058 | 315 | 540 | 584 | N/A |
3/31/2020 | 2,087 | 353 | 435 | 475 | N/A |
12/31/2019 | 2,115 | 391 | 330 | 366 | N/A |
9/30/2019 | 2,112 | 401 | 263 | 300 | N/A |
6/30/2019 | 2,108 | 412 | 196 | 234 | N/A |
3/31/2019 | 2,084 | 421 | 236 | 284 | N/A |
12/31/2018 | 2,059 | 431 | 277 | 334 | N/A |
9/30/2018 | 1,996 | 364 | 317 | 371 | N/A |
6/30/2018 | 1,932 | 298 | 357 | 407 | N/A |
3/31/2018 | 1,905 | 360 | 391 | 433 | N/A |
12/31/2017 | 1,878 | 421 | 425 | 460 | N/A |
9/30/2017 | 1,784 | -446 | N/A | 377 | N/A |
6/30/2017 | 1,690 | -1,312 | N/A | 294 | N/A |
3/31/2017 | 1,611 | -1,410 | N/A | 259 | N/A |
12/31/2016 | 1,533 | -1,507 | N/A | 224 | N/A |
9/30/2016 | 1,504 | -656 | N/A | 227 | N/A |
6/30/2016 | 1,475 | 196 | N/A | 230 | N/A |
3/31/2016 | 1,424 | 181 | N/A | 231 | N/A |
12/31/2015 | 1,372 | 167 | N/A | 232 | N/A |
9/30/2015 | 1,337 | 208 | N/A | 246 | N/A |
6/30/2015 | 1,302 | 249 | N/A | 261 | N/A |
3/31/2015 | 1,254 | 240 | N/A | 268 | N/A |
12/31/2014 | 1,206 | 230 | N/A | 274 | N/A |
9/30/2014 | 1,090 | 176 | N/A | 238 | N/A |
6/30/2014 | 975 | 122 | N/A | 202 | N/A |
3/31/2014 | 931 | 106 | N/A | 186 | N/A |
12/31/2013 | 887 | 90 | N/A | 170 | N/A |
9/30/2013 | 872 | 101 | N/A | 166 | N/A |
6/30/2013 | 856 | 113 | N/A | 162 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1515's forecast earnings growth (33.8% per year) is above the savings rate (2%).
Earnings vs Market: 1515's earnings (33.8% per year) are forecast to grow faster than the Hong Kong market (11.4% per year).
High Growth Earnings: 1515's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 1515's revenue (5.8% per year) is forecast to grow slower than the Hong Kong market (7.7% per year).
High Growth Revenue: 1515's revenue (5.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1515's Return on Equity is forecast to be low in 3 years time (11.9%).